Impact of COVID-19 on Management Strategies for Coronary and Structural Heart Disease Interventions.
Lina Ya'QoubMohammad AlqarqazVaikom S MahadevanMarwan SaadAkram Y ElgendyPublished in: Current cardiology reports (2022)
With the limited resources and significant burden on the healthcare system during the pandemic, changes have evolved in practice to provide care to the highest risk patients while minimizing unnecessary exposure during elective surgical or transcatheter procedures. The COVID-19 crisis has significantly impacted the management of patients with acute coronary syndromes, chronic coronary syndromes, and structural heart disease.
Keyphrases
- coronavirus disease
- sars cov
- coronary artery disease
- coronary artery
- healthcare
- end stage renal disease
- acute coronary syndrome
- ejection fraction
- pulmonary hypertension
- newly diagnosed
- public health
- palliative care
- chronic kidney disease
- primary care
- quality improvement
- patients undergoing
- physical activity
- respiratory syndrome coronavirus
- percutaneous coronary intervention
- aortic stenosis
- risk factors
- drug induced
- aortic valve